William E. Barlow

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with Fred Hutch Cancer Center, Cancer Research And Biostatistics

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 29 papers. Top paper: “Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings”.

Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.3842

N/A

3.0DataRank · unranked

48 citations

Charles D. Blanke, Michael LeBlanc, William E. Barlow, Riha Vaidya, Scott D. Ramsey +2 more

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(22)00739-2

N/A

2.0DataRank · unranked

102 citations

Priyanka Sharma, William E. Barlow, Julie R. Gralow, Shannon L. Puhalla, Carey K. Anders +16 more

Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7062

N/A

0.883DataRank · unranked

27 citations

Gary Zirpoli, William E. Barlow, G. Thomas Budd, Bryan McKiver, Lajos Pusztai +10 more

Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer

New England Journal of Medicine(2019)10.1056/nejmoa1811714

N/A

0.729DataRank · unranked

128 citations

William E. Barlow, Kathy S. Albain, Ted A. Vandenberg, Shaker R. Dakhil, Nagendra R. Tirumali +7 more

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.02344

N/A

0.646DataRank · unranked

17 citations

Jieling Miao, Lajos Pusztai, Matthew P. Goetz, Priya Rastogi, Patricia A. Ganz +17 more

Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226)

Biomarkers(2023)10.1080/1354750x.2023.2168063

N/A

0.587DataRank · unranked

12 citations

Adrian Nordmark, Amy Williams, Costanza Paoletti, William E. Barlow, Erin F. Cobain +11 more

Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1001

N/A

0.587DataRank · unranked

49 citations

Eve T. Rodler, William E. Barlow, Julie R. Gralow, Shannon Leigh Huggins-Puhalla, Carey K. Anders +15 more

Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial

npj Breast Cancer(2023)10.1038/s41523-023-00535-0

N/A

0.498DataRank · unranked

11 citations

Yalai Bai, Vasiliki Pelekanou, Zeina Nahleh, Saba Shafi, Sneha Burela +12 more

Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1562

N/A

0.457DataRank · unranked

20 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae314

N/A

0.443DataRank · unranked

10 citations

William E. Barlow, Julie R. Gralow, Funda Meric‐Bernstam, Kathy S. Albain, Daniel F. Hayes +19 more

Socioeconomic Deprivation and Health Care Use in Patients Enrolled in SWOG Cancer Clinical Trials

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.4008

N/A

0.396DataRank · unranked

13 citations

Riha Vaidya, Cathee Till, William E. Barlow, Mike LeBlanc, Scott D. Ramsey +2 more

Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.38191

N/A

0.362DataRank · unranked

6 citations

Aasthaa Bansal, Sean D. Sullivan, Gary H. Lyman, William E. Barlow, Kathryn B. Arnold +11 more

Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD

BMC Health Services Research(2022)10.1186/s12913-022-07835-4

N/A

0.284DataRank · unranked

4 citations

Ari Bell‐Brown, Karma L. Kreizenbeck, Kathryn Egan, Gary H. Lyman, Dawn L. Hershman +6 more

Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP)

JNCI Monographs(2025)10.1093/jncimonographs/lgae048

N/A

0.165DataRank · unranked

2 citations

Heather Gunn, Ju-Whei Lee, Stephanie L. Pugh, William E. Barlow, Eva Culakova +9 more

Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221

Cancer Chemotherapy and Pharmacology(2024)10.1007/s00280-024-04680-6

N/A

0.104DataRank · unranked

1 citations

Gary Zirpoli, G. Thomas Budd, William E. Barlow, Lajos Pusztai, Gabriel N. Hortobágyi +8 more

Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221

Research Square(2023)10.21203/rs.3.rs-3242513/v1

N/A

0.104DataRank · unranked

1 citations

Gary Zirpoli, G. Thomas Budd, William E. Barlow, Lajos Pusztai, Gabriel N. Hortobágyi +8 more

Association of measures of socioeconomic deprivation with healthcare utilization in elderly patients enrolled in SWOG cancer clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6527

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Cathee Till, William E. Barlow, Michael LeBlanc, Scott D. Ramsey +2 more

Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1076

N/A

0DataRank · unranked

0 citations

William E. Barlow, Costanza Paoletti, Mattias Bergqvist, Amy Williams, Hanna Ritzén +11 more

Impact of treatment experience on patient knowledge of colony-stimulating factors among patients receiving cancer chemotherapy: evidence from S1415CD—a large pragmatic trial

Supportive Care in Cancer(2023)10.1007/s00520-023-08056-z

N/A

0DataRank · unranked

0 citations

Aasthaa Bansal, Sean D. Sullivan, Kathryn B. Arnold, William E. Barlow, Dawn L. Hershman +3 more

Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial

UNC Libraries(2025)10.17615/dgtt-ap31

N/A

0DataRank · unranked

0 citations

Julie R. Gralow, Edith Perez, Kevin Kalinsky, Gabriel N. Hortobágyi, Nancy U. Lin +19 more

A pragmatic cluster-randomized trial of a computerized clinical decision support system to improve colony stimulating factor prescribing for patients with cancer receiving myelosuppressive chemotherapy (SWOG S1415CD).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1525

N/A

0DataRank · unranked

1 citations

Aasthaa Bansal, Sean D. Sullivan, Gary H. Lyman, William E. Barlow, Kathryn B. Arnold +10 more

Analysis of Pre- and Posttreatment Tissues from the SWOG S0800 Trial Reveals an Effect of Neoadjuvant Chemotherapy on the Breast Cancer Genome

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2405

N/A

0DataRank · unranked

18 citations

Vikram B. Wali, Xiaotong Li, William E. Barlow, Zeina Nahleh, Alastair M. Thompson +4 more

Intervention non-adherence in a pragmatic randomized trial of a standardized order entry for colony stimulating factor prescribing.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.374

N/A

0DataRank · unranked

0 citations

Aasthaa Bansal, William E. Barlow, Kathryn B. Arnold, Ari Bell‐Brown, Kate Watabayashi +5 more

Can order entry systems improve oncology practice? The TrACER Experience.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.339

N/A

0DataRank · unranked

0 citations

Aasthaa Bansal, William E. Barlow, Kathryn B. Arnold, Ari Bell‐Brown, Kate Watabayashi +5 more

A pragmatic cluster-randomized trial of a standing physician order entry intervention for colony stimulating factor use among patients at intermediate risk for febrile neutropenia (SWOG S1415CD).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1518

N/A

0DataRank · unranked

1 citations

Aasthaa Bansal, Sean D. Sullivan, Gary H. Lyman, William E. Barlow, Kathryn B. Arnold +10 more

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2019.5559

N/A

0DataRank · unranked

78 citations

William E. Barlow, Reshma Jagsi, Thomas A. Buchholz, Steven Shak, Frederick L. Baehner +13 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384.v1

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Data from Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor–Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial

(2023)10.1158/1078-0432.c.6530384

N/A

0DataRank · unranked

0 citations

William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow +9 more

Reply to Y. Wang et al and Q. Sui et al

Journal of Clinical Oncology(2023)10.1200/jco.23.00722

N/A

0DataRank · unranked

0 citations

William E. Barlow, W. Fraser Symmans, Corey Speers